Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis

Autor: Ryerson, Lana Zhovtis, Foley, John F, Defer, Gilles, Cohen, Jeffrey A, Arnold, Douglas L, Butzkueven, Helmut, Cutter, Gary, Giovannoni, Gavin, Killestein, Joep, Wiendl, Heinz, Sinks, Susie, Kuhelj, Robert, Bodhinathan, Karthik, Lasky, Tyler

Publikováno v: In Multiple Sclerosis and Related Disorders April 2023 72

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

Autor: van der Walt, Anneke, Dwyer, Christopher, Buzzard, Katherine, Spies, Judith, Parratt, John, van Pesch, Vincent, Willekens, Barbara, Perrotta, Gaetano, Bartholomé, Emmanuel, Grand'Maison, Francois, Jacques, Francois, Giacomini, Paul, Vosoughi, Reza, Girard, Jean-Marc, de Seze, Jerome, Lebrun Frenay, Christine, Ruet, Aurelie, Laplaud, David-Axel, Reifschneider, Gerd, Wagner, Bert, Rauer, Sebastian, Pul, Refik, Seipelt, Maria, Berthele, Achim, Klotz, Luisa, Kallmann, Boris-Alexander, Paul, Friedemann, Achiron, Anat, Lus, Giacomo, Centonze, Diego, Patti, Francesco, Grimaldi, Luigi, Hupperts, Raymond, Frequin, Stephan, Fermont, Jiske, Madueno, Sara Eichau, Alonso Torres, Ana Maria, Costa-Frossard França, Lucienne, Meca-Lallana, Jose Eustasio, Ruiz, Luis Brieva, Pearson, Owen, Rog, David, Evangelou, Nikolaos, Ismail, Azza, Lathi, Ellen, Fox, Edward, Leist, Thomas, Sloane, Jacob, Wu, Gregory, Khatri, Bhupendra, Steingo, Brian, Thrower, Ben, Gudesblatt, Mark, Calkwood, Jonathan, Bandari, Daniel, Scagnelli, John, Laganke, Christopher, Robertson, Derrick, Kipp, Lucas, Belkin, Martin, Cohan, Stanley, Goldstick, Lawrence, Courtney, Ardith, Vargas, Wendy, Sylvester, Andrew, Srinivasan, Jayshri, Kannan, Meena, Picone, Maryann, English, Jeffrey, Napoli, Salvatore, Balabanov, Roumen, Zaydan, Islam, Nicholas, Jacqueline, Kaplan, Jeffrey, Lublin, Fred, Riser, Emily, Miller, Tamara, Alvarez, Enrique, Wray, Sibyl, Gross, Jeffrey, Pawate, Siddharama, Hersh, Carrie, McCarthy, Lucas, Crayton, Heidi, Graves, Jennifer, Foley, John F ^*, Defer, Gilles, Ryerson, Lana Zhovtis, Cohen, Jeffrey A, Arnold, Douglas L, Butzkueven, Helmut, Cutter, Gary, Giovannoni, Gavin, Killestein, Joep, Wiendl, Heinz, Smirnakis, Karen, Xiao, Shan, Kong, George, Kuhelj, Robert, Campbell, Nolan

Publikováno v: In The Lancet Neurology July 2022 21(7):608-619

IN SCIENCE JOURNALS.

Autor: Smith, Jesse, Funk, Michael A., Stern, Peter, Osborne, Ian S., Smith, Keith T., Maroso, Mattia, Yeston, Jake S., Grocholski, Brent, Foley, John F., Sofowora, Iyinoluwa, Hurtley, Stella M., Ross, Sarah H., Simonti, Corinne, Stajic, Jelena

Publikováno v: Science; 7/26/2024, Vol. 385 Issue 6707, p402-404, 3p, 3 Color Photographs

Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosis.

Autor: Zhu, Wen, Chen, Chenyi, Zhang, Lili, Hoyt, Tammy, Walker, Elizabeth, Venkatesh, Shruthi, Zhang, Fujun, Qureshi, Ferhan, Foley, John F, Xia, Zongqi

Publikováno v: Brain Communications; 2024, Vol. 6 Issue 1, p1-12, 12p

An Insider's View

Autor: Ray, L. Bryan, Gough, Nancy R., Adler, Elizabeth M., Foley, John F.

Publikováno v: Science, 2007 Oct 01. 318(5847), 61-61.

Externí odkaz: https://www.jstor.org/stable/20048520